WEBSITE BSE:523489 NSE : CMM HOSPITAL 18 May, 12:50
Market Cap ₹25 Cr.
Stock P/E 63.9
P/B 180.8
Current Price ₹33.6
Book Value ₹ 0.2
Face Value 10
52W High ₹54.7
Dividend Yield 0%
52W Low ₹ 19.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 11 | 6 | 7 | 7 | 6 | 7 | 8 | 7 | 7 | 8 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 12 | 6 | 7 | 7 | 6 | 7 | 8 | 7 | 7 | 8 |
Total Expenditure | 7 | 6 | 6 | 7 | 6 | 6 | 7 | 6 | 7 | 7 |
Operating Profit | 5 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 4 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
Profit After Tax | 4 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 4 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Adjusted Earnings Per Share | 5.5 | 0.1 | 0.2 | -0.6 | 0 | 0.3 | 0.5 | 0 | 0.1 | -0.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 16 | 18 | 19 | 21 | 19 | 23 | 22 | 26 | 19 | 31 | 29 | 30 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Total Income | 16 | 18 | 19 | 21 | 19 | 24 | 23 | 26 | 20 | 32 | 29 | 30 |
Total Expenditure | 13 | 15 | 17 | 18 | 18 | 20 | 20 | 23 | 19 | 26 | 26 | 27 |
Operating Profit | 3 | 3 | 2 | 3 | 1 | 4 | 3 | 3 | 1 | 6 | 3 | 3 |
Interest | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Exceptional Income / Expenses | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 0 | -1 | 1 | -1 | 1 | 0 | 1 | -1 | 4 | 1 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 1 | 0 | -1 | 1 | -1 | 1 | 0 | 1 | -1 | 4 | 1 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 0 | -1 | 1 | -1 | 1 | 0 | 1 | -1 | 4 | 1 | 0 |
Adjusted Earnings Per Share | 0.9 | 0.6 | -1.3 | 0.9 | -1.4 | 2 | 0.1 | 0.7 | -1.7 | 5.3 | 1.2 | 0.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -6% | 4% | 5% | 6% |
Operating Profit CAGR | -50% | 0% | -6% | 0% |
PAT CAGR | -75% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 65% | 26% | 25% | 18% |
ROE Average | 0% | 0% | 0% | 0% |
ROCE Average | 21% | 27% | 24% | 23% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | -5 | -5 | -5 | -5 | -6 | -4 | -4 | -4 | -5 | -1 | 0 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 13 | 12 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
Other Non-Current Liabilities | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total Current Liabilities | 9 | 11 | 12 | 11 | 12 | 12 | 11 | 11 | 12 | 11 | 11 |
Total Liabilities | 17 | 19 | 19 | 18 | 18 | 19 | 19 | 19 | 19 | 21 | 22 |
Fixed Assets | 14 | 15 | 15 | 15 | 14 | 15 | 14 | 14 | 13 | 14 | 14 |
Other Non-Current Assets | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 7 | 8 |
Total Assets | 17 | 19 | 19 | 18 | 18 | 19 | 19 | 19 | 19 | 21 | 22 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 3 |
Cash Flow from Operating Activities | 5 | 4 | 4 | 2 | 3 | 2 | 2 | 3 | 3 | 4 | 3 |
Cash Flow from Investing Activities | -2 | -2 | -2 | -0 | -0 | -2 | -1 | -1 | -0 | -2 | -1 |
Cash Flow from Financing Activities | -3 | -2 | -2 | -1 | -1 | -1 | -1 | -2 | -1 | -2 | -1 |
Net Cash Inflow / Outflow | 0 | 0 | 0 | 0 | 1 | -1 | 0 | -0 | 2 | 0 | 1 |
Closing Cash & Cash Equivalent | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 3 | 5 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.92 | 0.6 | -1.3 | 0.88 | -1.42 | 2 | 0.07 | 0.74 | -1.67 | 5.32 | 1.19 |
CEPS(Rs) | 1.86 | 1.68 | 0.29 | 2.43 | 0.08 | 3.54 | 1.67 | 2.4 | 0.02 | 6.89 | 2.77 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -6.62 | -6.03 | -7.33 | -6.45 | -7.68 | -5.59 | -5.53 | -4.77 | -6.39 | -1.04 | 0.16 |
Core EBITDA Margin(%) | 17.36 | 14.39 | 11.34 | 14.68 | 6.82 | 16.25 | 9.43 | 9.51 | 3.27 | 18.3 | 10.5 |
EBIT Margin(%) | 13.78 | 10.48 | 2.18 | 9.7 | 1.62 | 12.29 | 6.31 | 7.51 | -0.57 | 15.81 | 7.61 |
Pre Tax Margin(%) | 4.27 | 2.69 | -5.15 | 3.19 | -5.52 | 6.38 | 0.22 | 2.13 | -6.41 | 12.67 | 4.48 |
PAT Margin (%) | 4.27 | 2.49 | -5.15 | 3.19 | -5.57 | 6.38 | 0.22 | 2.13 | -6.41 | 12.67 | 3.12 |
Cash Profit Margin (%) | 8.65 | 7.02 | 1.14 | 8.85 | 0.32 | 11.26 | 5.57 | 6.96 | 0.09 | 16.41 | 7.25 |
ROA(%) | 4.22 | 2.45 | -5.12 | 3.52 | -5.75 | 7.95 | 0.25 | 2.84 | -6.47 | 19.59 | 4.06 |
ROE(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ROCE(%) | 25.9 | 22.68 | 5.53 | 28.38 | 4.43 | 39.57 | 17.45 | 24.2 | -1.51 | 59.93 | 21.1 |
Receivable days | 9.53 | 10.2 | 10.82 | 9.6 | 10.68 | 10.44 | 13.02 | 13.36 | 17.3 | 9.94 | 13.39 |
Inventory Days | 9.13 | 8.88 | 8.42 | 9.8 | 12.39 | 11.04 | 11.74 | 9.33 | 11.82 | 5.66 | 5.26 |
Payable days | 142.23 | 109.37 | 105.02 | 90.57 | 86.61 | 80.82 | 85.77 | 69.08 | 103.41 | 92.34 | 108.32 |
PER(x) | 5.48 | 9.64 | 0 | 12.85 | 0 | 9.6 | 180.44 | 10.2 | 0 | 4.35 | 15.56 |
Price/Book(x) | -0.76 | -0.96 | -1.88 | -1.74 | -1.67 | -3.45 | -2.12 | -1.57 | -1.53 | -22.26 | 113.94 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.03 | 0.92 | 1.15 | 0.96 | 1.06 | 1.1 | 0.89 | 0.63 | 0.8 | 0.79 | 0.7 |
EV/Core EBITDA(x) | 5.68 | 6.15 | 9.61 | 6.27 | 14.14 | 6.39 | 7.67 | 5.08 | 13.54 | 4.02 | 5.95 |
Net Sales Growth(%) | 8.05 | 11.19 | 5.47 | 8.78 | -7.45 | 23.53 | -4.74 | 15.22 | -24.38 | 61.11 | -8.98 |
EBIT Growth(%) | 34.77 | -15.45 | -78.04 | 383.56 | -84.57 | 838.91 | -51.11 | 37.23 | -105.72 | 4580.38 | -56.19 |
PAT Growth(%) | 877.73 | -35.02 | -317.76 | 167.29 | -261.82 | 241.46 | -96.75 | 1028.92 | -327.6 | 418.14 | -77.6 |
EPS Growth(%) | 877.47 | -35.02 | -317.75 | 167.29 | -261.82 | 241.46 | -96.75 | 1028.99 | -327.58 | 418.15 | -77.6 |
Debt/Equity(x) | -2.68 | -2.83 | -2.22 | -2.53 | -2.13 | -2.94 | -2.96 | -3.22 | -2.41 | -13.68 | 87.39 |
Current Ratio(x) | 0.31 | 0.31 | 0.26 | 0.34 | 0.35 | 0.4 | 0.42 | 0.48 | 0.5 | 0.66 | 0.77 |
Quick Ratio(x) | 0.27 | 0.27 | 0.22 | 0.27 | 0.3 | 0.33 | 0.36 | 0.41 | 0.46 | 0.62 | 0.73 |
Interest Cover(x) | 1.45 | 1.35 | 0.3 | 1.49 | 0.23 | 2.08 | 1.04 | 1.4 | -0.1 | 5.04 | 2.43 |
Total Debt/Mcap(x) | 3.52 | 2.96 | 1.18 | 1.45 | 1.28 | 0.85 | 1.39 | 2.05 | 1.58 | 0.61 | 0.77 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 55.78 | 55.78 | 55.78 | 55.78 | 55.78 | 55.78 | 55.78 | 55.78 | 55.78 | 55.78 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Public | 44.08 | 44.08 | 44.08 | 44.08 | 44.08 | 44.08 | 44.08 | 44.08 | 44.08 | 44.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About